Opendata, web and dolomites

CARDIACSENSE SIGNED

A new clinically proven and reliable medical solution for continuous heart arrhythmia and blood pressure monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CARDIACSENSE project word cloud

Explore the words cloud of the CARDIACSENSE project. It provides you a very rough idea of what is the project "CARDIACSENSE" about.

encountered    fibrillation    boost    continuous    free    2025    surgery    small    connectivity    launch    htn    lives    sharing    besides    sensitive    revenues    israeli    introducing    start    healthcare    optical    finger    error    innovative    lack    risks    sensor    wearable    monitoring    mainly    ltd    consists    heart    clinically    vision    globally    accuracy    company    risk    20    2009    market    first    precise    vital    individuals    yearly    signal    device    800m    data    blood    cardiac    finalize    500bn    trl6    delivers    health    training    365    23    reliably    movements    save    bp    artefact    half    ischaemic    arrhythmia    unaware    atrial    measuring    mostly    detects    grade    costing    sense    cardiacsense    positive    pressure    medical    patients    500    storage    ppg    inflating    invasive    monitor    watch    signs    suffering    jobs    hypertension    af    5m    false    stroke    adults    proven    wrist    time    pulse    obtrusive    solution   

Project "CARDIACSENSE" data sheet

The following table provides information about the project.

Coordinator
CARDIACSENSE 

Organization address
address: 4 LESHEM ST
city: CAESARA
postcode: 3079825
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.cardiacsense.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARDIACSENSE IL (CAESARA) coordinator 50˙000.00

Map

 Project objective

Atrial fibrillation (AF) is the most common heart arrhythmia in adults and a major risk factor for ischaemic stroke (increased by 500%), costing globally around €500Bn/year. On the other hand, Hypertension (HTN) is a condition, mostly encountered in patients suffering from AF, although only half of these individuals have this condition under control, and only 20% are unaware that they have HTN. Besides the health risks associated with these conditions, there is a lack of non-obtrusive, non-inflating, non-invasive, small, precise, easy-to-use devices for continuous monitoring of vital signs, including AF and blood pressure. Cardiac Sense Ltd is an Israeli start-up established in 2009, with a vision of developing innovative non-invasive technology for monitoring vital signs. We are developing CardiacSense (TRL6), a clinically-proven medical solution that reliably delivers non-invasive and non-inflating heart arrhythmia and blood pressure monitoring, 23/365 for as long as needed. It mainly consists of a wearable (a watch), highly sensitive, error-free (introducing an artefact sensor), real-time measuring device, that is non-invasive (no surgery needed), easy to use (no training needed) and allows for a great connectivity (providing easy data storage and sharing). Our solution is based on optical PPG sensor technology to monitor heart AF and BP. In addition, we are the first company to develop a unique artefact sensor that detects finger and wrist movements that affect the PPG signal by increasing false positive results. Our solution thus has a medical grade accuracy level of pulse measurement. Through this project we aim to finalize its development and launch it to the market, with a potential to save around €800M to EU healthcare and save up to 5,000 lives yearly, and to boost our company's growth to €7.5M revenues, and 20 new jobs by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARDIACSENSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARDIACSENSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More